• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比利时医院门诊肠外抗菌治疗(OPAT)的组织质量与医院药剂师的作用:一项全国性调查。

Organisational quality and hospital pharmacists' roles of outpatient parenteral antimicrobial therapy (OPAT) in Belgian hospitals: a national survey.

作者信息

Kaes Anneleen, Buyle Franky, Quintens Charlotte, Van Eijgen Astrid, Zubryckyj Larissa, Boussery Koen, Vanoverschelde Anna

机构信息

Department of Bioanalysis, Pharmaceutical Care Unit, Ghent University, Ghent, Belgium.

Hospital Pharmacy Department, Ghent University Hospital, Ghent, Belgium.

出版信息

Acta Clin Belg. 2024 Oct;79(5):341-349. doi: 10.1080/17843286.2024.2448357. Epub 2025 Jan 11.

DOI:10.1080/17843286.2024.2448357
PMID:39799001
Abstract

OBJECTIVES

Implementation of outpatient parenteral antimicrobial therapy (OPAT), also known as intravenous (IV) antimicrobial treatment at home, has increased in recent years. Ensuring OPAT quality is crucial to achieve positive patient outcomes. However, data on the Belgian quality of OPAT organisation is lacking. We aimed to monitor the organisational quality of OPAT in Belgian hospitals and identify roles of hospital pharmacists involved in OPAT.

METHODS

A cross-sectional study applying a web-based survey on OPAT quality was conducted from 2 to 29 April 2024. The survey assessed the presence of six core and five non-core structure indicators, and OPAT-related tasks of hospital pharmacists.

RESULTS

Almost two-thirds (64%; 65/101) of Belgian hospitals answered the survey, with 77% of these hospitals providing OPAT, with an increase since 2023. All 11 structure indicators were present in 6% of hospitals, while 18% had all six core structure indicators.Three of the six core structure indicators were formally present in the majority of the hospitals: a policy on patient selection criteria (76%), a structured OPAT programme (70%), and a dedicated team (64%). In contrast, a system for fast communication between the patient and OPAT team members (50%), a mechanism for urgent clinical discussions (42%), and monitoring of quality indicators (28%) were not formally present in the majority of the hospitals. The primary tasks for hospital pharmacists included overseeing OPAT prescriptions and supplying antimicrobials and related materials.

CONCLUSION

While the adoption of OPAT is increasing among Belgian hospitals, significant opportunities remain for improving the quality of the OPAT organisation and expanding the OPAT-related tasks of Belgian hospital pharmacists.

摘要

目的

门诊胃肠外抗菌治疗(OPAT),即在家中进行静脉抗菌治疗,近年来有所增加。确保OPAT质量对于实现良好的患者治疗效果至关重要。然而,缺乏关于比利时OPAT组织质量的数据。我们旨在监测比利时医院OPAT的组织质量,并确定参与OPAT的医院药剂师的作用。

方法

于2024年4月2日至29日进行了一项横断面研究,采用基于网络的OPAT质量调查。该调查评估了六个核心和五个非核心结构指标的存在情况,以及医院药剂师与OPAT相关的任务。

结果

近三分之二(64%;65/101)的比利时医院回复了调查,其中77%的医院提供OPAT,自2023年以来有所增加。6%的医院具备所有11个结构指标,而18%的医院具备所有六个核心结构指标。六个核心结构指标中的三个在大多数医院中正式存在:患者选择标准政策(76%)、结构化OPAT计划(70%)和专门团队(64%)。相比之下,患者与OPAT团队成员之间的快速沟通系统(50%)、紧急临床讨论机制(42%)和质量指标监测(28%)在大多数医院中并未正式存在。医院药剂师的主要任务包括监督OPAT处方以及供应抗菌药物和相关材料。

结论

虽然比利时医院对OPAT的采用率在增加,但在改善OPAT组织质量和扩大比利时医院药剂师与OPAT相关任务方面仍有很大机会。

相似文献

1
Organisational quality and hospital pharmacists' roles of outpatient parenteral antimicrobial therapy (OPAT) in Belgian hospitals: a national survey.比利时医院门诊肠外抗菌治疗(OPAT)的组织质量与医院药剂师的作用:一项全国性调查。
Acta Clin Belg. 2024 Oct;79(5):341-349. doi: 10.1080/17843286.2024.2448357. Epub 2025 Jan 11.
2
Efficacy and safety of a Belgian tertiary care outpatient parenteral antimicrobial therapy (OPAT) program.比利时三级保健门诊患者抗菌治疗(OPAT)项目的疗效和安全性。
Infection. 2020 Jun;48(3):357-366. doi: 10.1007/s15010-020-01398-4. Epub 2020 Feb 14.
3
Outpatient parenteral antimicrobial therapy (OPAT) in the UK: a cross-sectional survey of acute hospital trusts and health boards.英国门诊胃肠外抗菌治疗(OPAT):急性医院信托机构和健康委员会的横断面调查
Diagn Microbiol Infect Dis. 2019 Jan;93(1):58-62. doi: 10.1016/j.diagmicrobio.2018.07.013. Epub 2018 Jul 24.
4
Survey of delivery of parenteral antimicrobials in non-inpatient settings across Europe.欧洲非住院环境下肠外抗菌药物给药情况调查。
Int J Antimicrob Agents. 2022 Apr;59(4):106559. doi: 10.1016/j.ijantimicag.2022.106559. Epub 2022 Feb 25.
5
[A practical program for outpatient parenteral antimicrobial therapy].[门诊胃肠外抗菌治疗实用方案]
J Pharm Belg. 2016 Sep(3):22-31.
6
OPAT: proof of concept in a peripheral Belgian hospital after review of the literature.门诊静脉抗生素治疗(OPAT):在回顾文献后,比利时一家周边医院的概念验证
Acta Clin Belg. 2018 Aug;73(4):257-267. doi: 10.1080/17843286.2018.1424503. Epub 2018 Jan 31.
7
Current Practices and Opportunities for Outpatient Parenteral Antimicrobial Therapy in Hospitals: A National Cross-Sectional Survey.医院门诊胃肠外抗菌治疗的当前实践与机遇:一项全国横断面调查
Antibiotics (Basel). 2022 Oct 1;11(10):1343. doi: 10.3390/antibiotics11101343.
8
Barriers and facilitators for the implementation and expansion of outpatient parenteral antimicrobial therapy: a systematic review.门诊胃肠外抗菌治疗实施与扩展的障碍及促进因素:一项系统综述
J Hosp Infect. 2024 May;147:1-16. doi: 10.1016/j.jhin.2024.02.006. Epub 2024 Feb 27.
9
Clinical characteristics and outcomes of patients receiving outpatient parenteral antibiotic therapy in a Belgian setting: a single-center pilot study.比利时门诊接受胃肠外抗生素治疗患者的临床特征及治疗结果:一项单中心试点研究
Acta Clin Belg. 2020 Aug;75(4):275-283. doi: 10.1080/17843286.2019.1608396. Epub 2019 Apr 25.
10
Best practices, implementation and challenges of outpatient parenteral antimicrobial therapy: results of a worldwide survey among healthcare providers.门诊胃肠外抗菌治疗的最佳实践、实施与挑战:医疗服务提供者的全球调查结果
Ther Adv Infect Dis. 2023 Dec 13;10:20499361231214901. doi: 10.1177/20499361231214901. eCollection 2023 Jan-Dec.

引用本文的文献

1
Delivery of Outpatient Parenteral Antimicrobial Therapy (OPAT) in an Ever-Changing National Health Service (UK): Benefits, Barriers, and Opportunities.在不断变化的英国国民医疗服务体系中提供门诊肠外抗菌治疗(OPAT):益处、障碍与机遇
Antibiotics (Basel). 2025 Apr 29;14(5):451. doi: 10.3390/antibiotics14050451.